Insilico Medicine
OrganizationHeard in 13 episodes across 5 shows since Aug 2026
A biotechnology company using artificial intelligence for drug discovery, target identification, molecular design, and aging-related research.
Episodes
First heard
Expert statements
Episodes per month
Public PodLume episodes featuring it, over the last year.
Show the data
| Month | Episodes |
|---|---|
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 1 |
| Sep 2026 | 8 |
| Oct 2026 | 1 |
| Nov 2026 | 3 |
Email alert
Email me when Insilico Medicine comes up on a podcast
One email a week at most, with the new episodes that mention Insilico Medicine. Free, no account needed, unsubscribe in one click.
What experts have said about Insilico Medicine
5 statements · 4 positive · 1 negative
Insilica lacks a proven business model and sustainable consistent profitability.
“it's a fairly recent float. We've described it as not really having a proven business model as yet.”
Open the episode · Morning Movers!Listen at 6:31
Insilico shares rose about 8% after releasing an obesity-targeting molecule.
“Insilico, which is an AI-driven drugs developer, that's up around 8% as it releases a molecule to perhaps tackle obesity”
Open the episode · Insilico Rises, Hygon Dips, AOU GainsListen at 1:11
“So that I think is quite positive actually, because we've been flagging for a while that the balance sheet's too thin and it does need more cash.”
Open the episode · Paul's Podcast - Fri 13 Mar 2026Listen at 21:12
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
13 episodes featuring Insilico Medicine, newest first
- Nov 17, 2026
NVIDIA weighs Jensen Huang’s return amid board scrutinyTech Brew Ride HomeNov 17, 2026 - Nov 17, 2026
AI chip curbs split Asian marketsStock MoversNov 17, 2026 - Nov 16, 2026
AI selloff pushes Asian investors toward defensive sectorsStock MoversNov 16, 2026 - Oct 15, 2026
AI’s leap from solving math to reshaping abundanceMoonshots with Peter DiamandisOct 15, 2026 - Sep 30, 2026
Asian markets split between drug optimism and chip anxietyStock MoversSep 30, 2026 - Sep 29, 2026
AI doubts hit Taiwan chips as Asian markets divergeStock MoversSep 29, 2026